Current Outpatient Cardiac Rehabilitation in Austria

Cardiovascular Diseases Clinical Trial

Official title:

Outpatient Cardiac Rehabilitation in Austria

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03463486
• Other study ID #: UISM-11
• Status: Completed
• Start date: January 2005
• Est. completion date: December 2021

Study information

• Verified date: April 2022
• Source: Paracelsus Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Aim of this study is to give evidence to outpatient cardiac rehabilitation in Austria. The database created in this context is supposed to pave the way as instrument to document and comprehend quality of outpatient cardiac rehabilitation in Austria as a key for quality management. Analyses of the created database should be made on a regular basis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8000
• Est. completion date: December 2021
• Est. primary completion date: December 2018
• Gender: All
• Age group: 12 Years to 99 Years

Eligibility

Inclusion Criteria:

Any patient who meets inclusion criteria for outpatient cardiac rehabilitation in Austria -

Exclusion Criteria:

• Medical conditions which prevent patients from complying with the exercise program

• Acute infections

• Hypertrophic cardiomyopathy

• Pulmonary artery embolism or phlebothrombosis within the previous 6 months

• Unstable angina pectoris

• Heart failure (NYHA IV)

• Hemodynamically unstable arrhythmia

Related Conditions & MeSH terms

• Cardiovascular Diseases

Intervention

Behavioral:
• Physical activity
50min of endurance training combined with 50min of calisthenics; 1-3x/wekk; 6weeks up to 1year

Locations

Country	Name	City	State
Austria	Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University	Salzburg

Sponsors (1)

Lead Sponsor	Collaborator
Paracelsus Medical University

Country where clinical trial is conducted

Austria, 

References & Publications (3)

Adams V, Reich B, Uhlemann M, Niebauer J. Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium. Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H72-H88. doi: 10.1152/ajpheart.00470.2016. Epub 2017 May 5. Review. — View Citation

Niebauer J, Hambrecht R, Velich T, Hauer K, Marburger C, Kälberer B, Weiss C, von Hodenberg E, Schlierf G, Schuler G, Zimmermann R, Kübler W. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation. 1997 Oct 21;96(8):2534-41. — View Citation

Niebauer J, Mayr K, Harpf H, Hofmann P, Müller E, Wonisch M, Pokan R, Benzer W. Long-term effects of outpatient cardiac rehabilitation in Austria: a nationwide registry. Wien Klin Wochenschr. 2014 Mar;126(5-6):148-55. doi: 10.1007/s00508-014-0527-3. Epub — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline in Physical Work Capacity (PWC) in Phase II rehabilitation	PWC is measured by a graded exercise test on a cycle ergometer at start and end of outpatient cardiac rehabilitation	6 weeks
Primary	Change from baseline in Physical Work Capacity (PWC) in Phase III rehabilitation	PWC is measured by a graded exercise test on a cycle ergometer at start and end of outpatient cardiac rehabilitation	1 year
Secondary	Change from baseline in Cholesterol in Phase II rehabilitation	Venous blood samples are taken to assess Cholesterol	6 weeks
Secondary	Change from baseline in Cholesterol in Phase III rehabilitation	Venous blood samples are taken to assess Cholesterol	1 year
Secondary	Change from baseline in Triglycerides in Phase II rehabilitation	Venous blood samples are taken to assess Triglycerides	6 weeks
Secondary	Change from baseline in Triglycerides in Phase III rehabilitation	Venous blood samples are taken to assess Triglycerides	1 year
Secondary	Change from baseline in Blood Glucose in Phase II rehabilitation	Venous blood samples are taken to assess blood glucose	6 weeks
Secondary	Change from baseline in Blood Glucose in Phase III rehabilitation	Venous blood samples are taken to assess blood glucose	1 year

External Links

•   Institute of Sports Medicine, Prevention and Rehabilitation
•   Paracelsus Medical University Salzburg, Austria